Postdoctoral researcher, Hubrecht Institute, Hans Clevers Lab
BIOGRAPHY
OCT 25, 2018 8:00 AM PDT
Share
Disease modeling and cancer therapy in stem cell-derived 3D organoid systems
Speaker
Abstract
DATE: October 25, 2018
TIME: 08:00am PDT, 11:00am EDT
While the significance of the microbiome is unprecedented, a thorough study to dissect the role of individual populations of the natural gut microbiome in healthy and diseased states is still lacking. Currently available in-vitro models of the human intestine have certain limitations, e.g., lack of immune cells or microbiota. Therefore, systems closely mirroring the human intestine are needed to gain a better understanding of intestinal dysfunction, host - pathogen interactions and for the development of more effective therapies for cancer. It is important to establish a patient derived, fast and efficient system which would mimic the in-vivo architecture in humans and permit precise studies on interactions of the gut microbes with the epithelium and the immune cells. The in-vitro 3D “mini-gut” system developed in the Clevers lab displays many important functions of the normal intestinal epithelium. Along with the developed toolbox for the analysis of these organoids (including FACS-based cell sorting, confocal imaging, RNA Sequencing, mass-spec proteomics and CRISPR-Cas9), it has proven to serve as a powerful system to investigate regulatory and pathological mechanisms of the intestinal epithelium on a molecular level.
To this end, we are developing a triple co-culture system of epithelial cells, immune cells and microbes to better understand the functional role of the gut microbiota, enabling personalized healthcare for the benefit of patients suffering from GI tract diseases. It might be possible in the future to determine the microbiome composition of cancer patients and provide personalized immunotherapy drug treatment.
Learning Objectives:
-
Organoids can be used for studying cancer and hereditary diseases, as well as in the examination of host cell–microorganism interactions.
-
Patient-derived organoids may enable personalized medicine.
-
Identify categories of individuals at risk of acquiring HDV infection.
You May Also Like
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
MAY 17, 2022
9:00 AM PDT
MAY 17, 2022
9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 28, 2022
7:00 AM PDT
JUN 28, 2022
7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
APR 26, 2022
7:00 AM PDT
C.E. CREDITS
APR 26, 2022
7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
AUG 16, 2022
11:00 AM PDT
AUG 16, 2022
11:00 AM PDT
Date: August 16, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing pers...
JUN 21, 2022
6:00 AM PDT
JUN 21, 2022
6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
OCT 25, 2018 8:00 AM PDT
Share
Disease modeling and cancer therapy in stem cell-derived 3D organoid systems
Loading Comments...
Finish Registering
-
JUN 29, 2022Lab Compliance Connect -
AUG 24, 2022Ignite Impact: Inherited Disease Summit
-
SEP 06, 2022Microbiology Virtual Week 2022
-
SEP 14, 20222nd USDA Food Loss and Waste Innovation Fair
- See More
-
AUG 16, 2022
-
AUG 16, 2022
-
AUG 16, 2022
- See More
